Pharmaceutical pesticide intermediates

Unipharm Pharmaceutical Industry Co., Ltd. is an innovative technology enterprise focused on the R&D, production, sales, and custom synthesis of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. With a registered capital of RMB 10 million, the company is located 130 meters north of Xinghai Street, east of Hailin Road, Weifang Binhai Economic Development Zone, Shandong Province.

The company is dedicated to the development of high-end compounds and intermediates, achieving domestically advanced levels in nitrogen-containing heterocyclic derivatives, halogenated organic compounds, chiral compounds, and aromatic compounds. Leveraging the global operational perspective, industry-leading R&D platforms, and stringent quality control systems of its parent group, Unipharm keeps pace with global pharmaceutical intermediate trends, rapidly scaling up production of new products. Its clients include R&D laboratories at universities/research institutes and commercial enterprises in pharmaceuticals, biotechnology, and chemical/petrochemical industries, with products distributed worldwide.

Equipped with a fully functional pilot plant and robust quality control systems, the company utilizes advanced analytical instruments including LC-MS, GC-MS, ICP-MS, HPLC, GC, and a 400MHz NMR (via third-party partnerships) to ensure rigorous quality assurance for all products.

Unipharm boasts a highly skilled management team and R&D professionals, supported by collaborations with key domestic and international university laboratories. It offers end-to-end capabilities from laboratory-scale development to pilot and industrial-scale production, comprehensively meeting custom synthesis and contract manufacturing needs.